Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 18603901000001113 | Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 52666301000001115 | Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) infusion 500ml bottles (Fresenius Kabi Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Is a | Glucose 5% / Lidocaine 1g/500ml (0.2%) solution for injection 500ml polyethylene bottles | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has active ingredient | Glucose anhydrous | false | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has specific active ingredient | Glucose anhydrous | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has active ingredient | Lidocaine | false | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has dispensed dose form | Infusion | true | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle | Is pack of | False | Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Inferred relationship | Existential restriction modifier | |
| Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle | Has AMP | True | Polyfusor LE glucose 5% / lidocaine 1g/500ml (0.2%) solution for injection 500ml bottles (Fresenius Kabi Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR